Drugs / DTPa-IPV/Hib vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00325156 | Nov 2004 → Aug 2007 | diphtheria, haemophilus infectious disease, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-IPV/Hib vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00325156 ↗ |
| Modality | Vaccine | “DTPa-IPV/Hib vaccine” NCT00325156 ↗ |
| Route | Intramuscular | “4 intramuscular injections” NCT00325156 ↗ |